Journal
LIPIDS
Volume 44, Issue 9, Pages 777-785Publisher
WILEY
DOI: 10.1007/s11745-009-3322-6
Keywords
Marine two-headed sphingolipid-like compound; Anticarcinogenic properties; Tumor cells; p53-dependent apoptosis
Funding
- Russian Science Schools, Program of Presidium of RAS [2813.2008.4]
- RFFI [RFFI 09-04-00015-a]
- FEB RAS [09-III-A-05-139, 09-III-A-05-146]
- KOSEF
Ask authors/readers for more resources
Rhizochalin [(2R,3R,26R,27R)-2,27-diamino-3-hydroxy-26-[(2R,3R,4S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy]octacosan-11-one], an antimicrobial and cytotoxic marine two-headed sphingolipid-like natural product, isolated from the sponge Rhizochalina incrustata, and some related compounds were studied as anticarcinogenic and proapoptotic agents. The corresponding effects were tested on the mouse skin epidermal JB6 P+ Cl 41 cell line, its stable transfectants, THP-1, HeLa, and SNU-C4 human tumor cells using a variety of assessments, including cell viability (MTS), flow cytometry, anchorage-independent soft agar, and luciferase assays. At 5-10 mu M concentrations, rhizochalin was effective as an inhibitor of the malignant transformation of JB6 P+ Cl 41 cells or colony formation of human tumor cells, which exerted its action, at least in part, through the induction of p53-dependent apoptosis. Structure-activity relationship study showed aglycon of rhizochalin to be the most active while peracetylated aglycon was the least active among the compounds studied.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available